Association of Helicobacter pylori infection with diabetes mellitus and diabetic nephropathy: A meta-analysis of 39 studies involving more than 20,000 participants

Scandinavian Journal of Infectious Diseases

Volumn 45, Issue 12, 2013, Pages 930-938

  Wang, Feng ^a   Liu, Juan ^a   Lv, Zongshun ^b  

^a TIANJIN PEOPLE'S HOSPITAL   (China)

^b Department of Anesthesiology   (China)

Author keywords

Diabetes mellitus; Helicobacter pylori; Nephropathy; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Indexed keywords

ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETOGENESIS; DISEASE ASSOCIATION; HELICOBACTER INFECTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; SYSTEMATIC REVIEW;

DIABETES COMPLICATIONS; DIABETIC NEPHROPATHIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; ODDS RATIO;

EID: 84887861096     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2013.844351     Document Type: Article

References (58)

1. Bener A, Uduman SA, Ameen A, Alwash R, Pasha MA, Usmani MA, et al. Prevalence of Helicobacter pylori infection among low socio-economic workers. J Commun Dis 2002; 34: 179-84.
2. Das JC, Paul N. Epidemiology and pathophysiology of Helicobacter pylori infection in children. Indian J Pediatr 2007; 74: 287-90.
3. Khalifa M M, Sharaf RR, Aziz RK. Helicobacter pylori: a poor man ' s gut pathogen?. Gut Pathogens 2010; 2: 2.
4. IARC Working Group on the Evaluation of the Carcinogenic Risks to Humans. Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 177-240.
5. Clarke M, Horton R. Bringing it all together: Lancet-Cochrane collaborate on systematic reviews. Lancet 2001; 357: 1728.
6. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
7. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
8. Egger M, Smith G D. Misleading meta-analysis. BMJ 1995; 311: 753-4.
9. Athanasiou T, Al-Ruzzeh S, Kumar P, Crossman MC, Amrani M, Pepper JR, et al. Off-pump myocardial revascularization is associated with less incidence of stroke in elderly patients. Ann Thorac Surg 2004; 77: 745-53.
10. Longo-Mbenza B, Nsenga J N, Mokondjimobe E, Gombet T, Assori IN, Ibara JR, et al. Helicobacter pylori infection is identifi ed as a cardiovascular risk factor in Central Africans. Vasc Health Risk Manag 2012; 6: 455-61.
11. Jeon CY, Haan MN, Cheng C, Clayton ER, Mayeda ER, Miller JW, et al. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care 2012; 35: 520-5.
12. Talebi-Taher M, Mashayekhi M, Hashemi MH, Bahrani V. Helicobacter pylori in diabetic and non-diabetic patients with dyspepsia. Acta Med Iran 2012; 50: 315-8.
13. Oluyemi A, Anomneze E, Smith S, Fasanmade O. Prevalence of a marker of active Helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria. BMC Res Notes 2012; 5: 284.
14. Chen Y, Blaser M J. Association between gastric Helicobacter pylori colonization and glycated hemoglobin levels. J Infect Dis 2012; 205: 1195-202.
15. El-Eshmawy M M, El-Hawary AK, Abdel Gawad SS, El-Baiomy AA. Helicobacter pylori infection might be responsible for the interconnection between type 1 diabetes and autoimmune thyroiditis. Diabetol Metab Syndr 2011; 3: 28.
16. A grawal RP, Sharma R, Garg D, Pokharna R, Kochar DK, Kothari RP. Role of Helicobacter pylori in causation of diabetic gastropathies and non-gastrointestinal complications in type 2 diabetes. J Indian Med Assoc 2010; 108: 140-3.
17. Sfarti C, Trifan A, Hutanasu C, Cojocariu C, Singeap AM, Stanciu C. Prevalence of gastroparesis in type 1 diabetes mellitus and its relationship to dyspeptic symptoms. J Gastrointestin Liver Dis 2010; 19: 279-84.
18. Ibrahim A, Zaher T, Ghonemy TA, El-Azim SA, El-Azim MA, Ramadan A. Impact of cytotoxin-associated gene A of Helicobacter pylori strains on microalbuminuria in type 2 diabetes. Saudi J Kidney Dis Transpl 2010; 21: 694-700.
19. Devrajani BR, Shah SZ, Soomro A A, Devrajani T. Type 2 diabetes mellitus: a risk factor for Helicobacter pylori infection: a hospital based case-control study. Int J Diabetes Dev Ctries 2010; 30: 22-6.
20. Krause I, Anaya JM, Fraser A, Barzilai O, Ram M, Abad V, et al. Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members. Ann N Y Acad Sci 2009; 1173: 633-9.
21. Cabral VL, Patrício FR, Gabbay MA, Dib SA, Miszputen SJ. Intraepithelial lymphocytes in duodenum from Brazilian adolescents with type 1 diabetes. Influence of Helicobacter pylori. Pediatr Diabetes 2009; 10: 316-20.
22. Ariizumi K, Koike T, Ohara S, Inomata Y, Abe Y, Iijima K, et al. Incidence of refl ux esophagitis and H pylori infection in diabetic patients. World J Gastroenterol 2008; 14: 3212-7.
23. Hamed SA, Amine NF, Galal GM, Helal SR, Tag El-Din LM, Shawky OA, et al. Vascular risks and complications in diabetes mellitus: the role of helicobacter pylori infection. J Stroke Cerebrovasc Dis 2008; 17: 86-94.
24. Demir M, Gokturk H S, Ozturk N A, Kulaksizoglu M, Serin E, Yilmaz U. Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications. Dig Dis Sci 2008; 53: 2646-9.
25. Bener A, Micallef R, Afifi M, Derbala M, Al-Mulla H M, Usmani MA. Association between type 2 diabetes mellitus and Helicobacter pylori infection. Turk J Gastroenterol 2007; 18: 225-9.
26. Jaber SM. Helicobacter pylori seropositivity in children with chronic disease in Jeddah, Saudi Arabia. Saudi J Gastroenterol 2006; 12: 21-6.
27. Gulcelik N E, Kaya E, Demirbas B, Culha C, Koc G, Ozkaya M, et al. Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. J Endocrinol Invest 2005; 28: 214-7.
28. Gillum RF. Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic infl ammation: the Third National Health and Nutrition Examination Survey. J Natl Med Assoc 2004; 96: 1470-6.
29. Altannavch Ts, Roubalová K, Broz J, Hrubá D, And e? l M. Serological markers of Chlamydia pneumoniae, cytomegalovirus and Helicobacter pylori infection in diabetic and nondiabetic patients with unstable angina pectoris. Cent Eur J Public Health 2003; 11: 102-6.
30. Candelli M, Rigante D, Marietti G, Nista EC, Crea F, Bartolozzi F, et al. Helicobacter pylori, gastrointestinal symptoms, and metabolic control in young type 1 diabetes mellitus patients. Pediatrics 2003; 111: 800-3.
31. Maule S, Lombardo L, Rossi C, Crocellà L, Masoero G, Della Monica P, et al. Helicobacter pylori infection and gastric function in primary autonomic neuropathy. Clin Auton Res 2002; 12: 193-6.
32. Anastasios R, Goritsas C, Papamihail C, Trigidou R, Garzonis P, Ferti A. Helicobacter pylori infection in diabetic patients: prevalence and endoscopic fi ndings. Eur J Intern Med 2002; 13: 376.
33. Cenerelli S, Bonazzi P, Galeazzi R, Testa I, Bonfi gli A R, Sirolla C, et al. Helicobacter pylori masks differences in homocysteine plasma levels between controls and type 2 diabetic patients. Eur J Clin Invest 2002; 32: 158-62.
34. Ko G T, Chan F K, Chan W B, Sung J J, Tsoi C L, To K F, et a l. Helicobacter pylori infection in Chinese subjects with type 2 diabetes. Endocr Res 2001; 27: 171-7.
35. Xia HH, Talley NJ, Kam EP, Young LJ, Hammer J, Horowitz M. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001; 96: 1039-46.
36. Marrollo M, Latella G, Melideo D, Storelli E, Iannarelli R, Stornelli P, et al. Increased prevalence of Helicobacter pylori in patients with diabetes mellitus. Dig Liver Dis 2001; 33: 21-9.
37. Quatrini M, Boarino V, Ghidoni A, Baldassarri AR, Bianchi PA, Bardella MT. Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms. J Clin Gastroenterol 2001; 32: 215-7.
38. Dore M P, Bilotta M, Malaty H M, Pacifi co A, Maioli M, Graham DY, et al. Diabetes mellitus and Helicobacter pylori infection. Nutrition 2000; 16: 407-10.
39. Rosenstock S J, Jør gensen T, Andersen L P, Bonnevie O. A ssociation of Helicobacter pylori infection with lifestyle, chronic disease, body-indices, and age at menarche in Danish adults. Scand J Public Health 2000; 28: 32-40.
40. Arslan D, Kendirci M, Kurtoglu S, Kula M. H elicobacter pylori infection in children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab 2000; 13: 553-6.
41. Güvener N, Akcan Y, Paksoy I, Soylu AR, Aydin M, Arslan S, et al. Helicobacter pylori associated gastric pathology in patients with type II diabetes mellitus and its relationship with gastric emptying: the Ankara study. Exp Clin Endocrinol Diabetes 1999; 107: 172-6.
42. Salardi S, Cacciari E, Menegatti M, Landi F, Mazzanti L, Stella FA, et al. Helicobacter pylori and type 1 diabetes mellitus in children. J Pediatr Gastroenterol Nutr 1999; 28: 307-9.
43. Gentile S, Turco S, Oliviero B, Torella R. The role of autonomic neuropathy as a risk factor of Helicobacter pylori infection in dyspeptic patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 1998; 42: 41-8.
44. Gasbarrini A, Ojetti V, Pitocco D, De Luca A, Franceschi F, Candelli M, et al. Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus. Eur J Gastroenterol Hepatol 1998; 10: 469-72.
45. de Luis DA, de la Calle H, Roy G, de Argila CM, Valdezate S, Canton R, et al. Helicobacter pylori infection and insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1998; 39: 143-6.
46. Pocecco M, Buratti E, Tommasini A, Torre G, Not T. H igh risk of Helicobacter pylori infection associated with cow ' s milk antibodies in young diabetics. Acta Paediatr 1997; 86: 700-3.
47. Ohnishi M, Fukui M, Ishikawa T, Ohnishi N, Ishigami N, Yoshioka K, et al. Helicobacter pylori infection and arterial stiffness in patients with type 2 diabetes mellitus. Metabolism 2008; 57: 1760-4.
48. de Luis DA, Lahera M, Cantón R, Boixeda D, San R omá n AL, Aller R, et al. Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care 1998; 21: 1129-32.
49. Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis 1993; 168: 219-21.
50. Kosunen TU, Aromaa A, Knekt P, Salomaa A, Rautelin H, Lohi P, et al. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 1997; 119: 29-34.
51. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A 1993; 90: 5791-5.
52. A therton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specifi c vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-7.
53. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-5.
54. Wellen K E, Hotamisligil G S. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111-9.
55. Manco M, Putignani L, Bottazzo GF. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 2010; 31: 817-44.
56. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991; 32: 1473-7.
57. Loscalzo J. Lipoprotein(a): a unique risk factor for atherothrombotic disease. Arteriosclerosis 1990; 10: 672-9.
58. Bliss C M Jr, Golenbock D T, Keates S, Linevsky J K, Kelly CP. Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil- activating peptide 78, and monocyte chemotactic protein 1 by human monocytes. Infect Immun 1998; 66: 5357-63.